www.celebrex-200mg.com

Su confiable suministrador de medicamentos genéricos.

Revise suprima
Site search
Obvious advantage Tell a friend and get discount! Want to give it a try?
Lista de categorías

Genérico Montelukast - Singulair

Búsqueda por letra:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Singulair

Genérico Singulair

Montelukast 4/5/10mg

El Singulair Genérico es utilizado en la prevención y tratamiento a largo plazo del asma. También es utilizado en algunos pacientes para aliviar la secreción nasal causada por la alergia y para prevenir los ataques de asma ocasionados por el ejercicio.
Más informaión »

$0.96 Comprar!
Choose Your language:
Bookmarks sociales
Testimonios de nuestros clientes

Debo excusarme - pensaba que ustedes querian engañarme. Pero la demora era causada por un error. Recibí el encargo el jueves 8 de junio, y el otro el sábado 10 de junio. ¡ Tardo casi un mes pero fue a causa de un error en los datos de envio! Muchas gracias. - Curt

Special Offer!

Nuevo

  • Can Montelukast Reduce the Frequency of URTI in Children? - Medscape

    Can Montelukast Reduce the Frequency of URTI in Children?MedscapeMontelukast selectively inhibits leukotriene receptors, thereby limiting the ability of leukotrienes to trigger inflammation.

  • Loopholes in pharma pricing policy - Hindu Business Line

    Hindu Business LineLoopholes in pharma pricing policyHindu Business LineAmong drugs used in asthma we have salbutamol and the rarely used ipratropium, whereas other frequently used drugs in asthma such as terbutaline, salmeterol, formeterol, bambuterol, theophylline, doxofylline, montelukast and zafirlukast will be out of .

  • Major Pharmaceuticals Prepare Themselves for Patent Expirations in 2012 - MarketWatch (press release)

    Major Pharmaceuticals Prepare Themselves for Patent Expirations in 2012MarketWatch (press release)Merck's worldwide sales of SINGULAIR (montelukast sodium), a once-a-day oral medicine for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis, grew 1 percent from the first quarter of 2011 to $1.

  • Strong profit growth and Zetia patent win for Merck & Co - Pharma Times

    Strong profit growth and Zetia patent win for Merck & CoPharma TimesMerck's best-selling treatment was once again the asthma/allergic rhinitis drug Singulair (montelukast), which inched up 1% to $1.

  • Asthma drugs: What every parent should know - Philadelphia Inquirer

    Philadelphia InquirerAsthma drugs: What every parent should knowPhiladelphia InquirerAnother preventive asthma medicationis Montelukast (Singulair), a pill taken at night that also helps nasal stuffiness.

Agregar a favoritos
Apuntarse a lista de correo
Trusted. Rx approved.